Non-Small Cell Lung Cancer Market

Increase in the understanding of diseases and research into the development of new drugs for non-small cell lung cancer is fueling the market growth. Market Size – USD 6.45 Billion in 2018, Market Growth - CAGR of 6.2%, Market Trends – The rise in the prevalence of lung cancer. The Global  Non-Small Cell Lung Cancer Market  is forecast to reach USD 10.53 Billion by 2026, according to a new report by Reports and Data. Non-small cell lung cancer accounts for approximately 85% of all lung cancers. The rise in the number of people suffering from non-small cell lung cancer is one of the major factors driving the global non-small cell lung cancer drugs market growth. The risk factors such as air pollution, cigarette smoking, passive smoking, and occupational exposure are increasing the incidence of the disease globally. One of the major drivers of the non-small cell lung cancer is the strong drug pipeline and recent drug approvals. The innovation of new drugs and their approvals for